Cargando…
Friend or foe—IDH1 mutations in glioma 10 years on
The identification of recurrent point mutations in the isocitrate dehydrogenase 1 (IDH1) gene, albeit in only a small percentage of glioblastomas a decade ago, has transformed our understanding of glioma biology, genomics and metabolism. More than 1000 scientific papers have been published since, pr...
Autor principal: | Huang, L Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875900/ https://www.ncbi.nlm.nih.gov/pubmed/31504231 http://dx.doi.org/10.1093/carcin/bgz134 |
Ejemplares similares
-
TLR9 and Glioma: Friends or Foes?
por: Fehri, Emna, et al.
Publicado: (2022) -
Tumor-Associated Macrophages in Glioma: Friend or Foe?
por: Kennedy, Benjamin C., et al.
Publicado: (2013) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
NFKB1 and Cancer: Friend or Foe?
por: Concetti, Julia, et al.
Publicado: (2018) -
Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019)